Omega Reports Third Quarter 2026 Results and Recent Developments
Business Wire•03/11/2026•16:15 ET
0
Key Highlights
- ➤2026 Adjusted FFO guidance raised to $3.28-$3.30 per diluted share
- ➤$1.5 billion invested year-to-date, including $946 million since quarter-end
- ➤Q3 AFFO $262 million, or $0.82 per share, versus $0.79
- ➤32 Florida SNFs transitioned to PACS, raising annual rent by $26.1 million
- ➤$846 million U.K. mortgage loan funded at 8.72% interest
Expert Statements
Matthew Gourmand, Chief Executive Officer of Omega Healthcare Investors
“We are pleased to report strong third quarter results, as we continued to grow FAD per share year over year, while reducing leverage to the lowest level in the Company’s history. As a result, we were again able to increase our AFFO guidance, moving the midpoint up by five cents to $3.29.”
Matthew Gourmand, Chief Executive Officer of Omega Healthcare Investors
“The investments made in the third and early fourth quarter highlight the breadth of opportunities available to us to continue to grow shareholder value. The pipeline remains strong, and we expect to make further accretive investments through the remainder of this year and into early 2027.”
Matthew Gourmand, Chief Executive Officer of Omega Healthcare Investors
“Importantly, the backdrop that has allowed us to deliver strong shareholder returns over the past few years remains in place. Operating metrics continue to be robust, with operator coverage further improving in the quarter, and we have a strong balance sheet and cost of capital that should allow us to continue to accretively invest.”
Omega Reports Third Quarter 2026 Results and Recent Developments
Completed $1.5 Billion in New Investments Year-to-Date, Including $946 Million Since Quarter-End Raises Full Year 2026 Guidance
Get started
Create a free account to read the full story.